Psychometric validation of the rhinitis control assessment test: A brief patient-completed instrument for evaluating rhinitis symptom control

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 2, 2010, Pages 118-124

  Schatz, Michael ^a   Meltzer, Eli O ^b   Nathan, Robert ^c   Derebery, M Jennifer ^d   Mintz, Matthew ^e   Stanford, Richard H ^f   Dalal, Anand A ^f   Silvey, Mary Jane ^f   Kosinski, Mark ^g  

^a KAISER PERMANENTE   (United States)

^b ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^c Asthma & Allergy Associates PC and Research Center   (United States)

^d HOUSE EAR INSTITUTE   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f GLAXOSMITHKLINE   (United States)

^g QualityMetric   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; EPIPHORA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; OUTCOME ASSESSMENT; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PSYCHOMETRY; SLEEP DISORDER; SNEEZING; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 76649136195     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2009.11.063     Document Type: Article

References (25)

1. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007; 28:3-9.
2. Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99: S808-S814.
3. Hopper JL, Jenkins MA, Carlin JB, Giles GG. Increase in the selfreported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study. Aust J Public Health. 1995;19:120 -124.
4. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758 -764.
5. Huurree TM, Aro HM, Jaakkola JJ. Incidence and prevalence of asthma and allergic rhinitis: a cohort study of Finnish adolescents. J Asthma. 2004;41:311-317.
6. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol. 1997;99:S742-S749.
7. Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:171-176.
8. Meltzer EO, Nathan RA, Selner JC, Storms W. Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol. 1997; 99:S815-S819.
9. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004;130:617- 629.
10. Crystal-Peters J, Crown WG, Goetzel RZ, et al. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6: 373-378.
11. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120:381-387.
12. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12: 963-974.
13. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117:549 -556.
14. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Dept of Health and Human Services, National Heart, Lung, and Blood Institute; 2007. NIH publication 07-4051.
15. Dowson AJ, Sender J, Lipscombe S, et al. Establishing principles for migraine management in primary care. Int J Clin Pract. 2003;57: 493-507.
16. Stull DE, Krouse J, Meltzer EO, et al. Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. Value Health. 2007;10:457- 465.
17. Petersen KD, Kronborg C, Gyrd-Hansen D, Dahl R, Larsen JN, Lowenstein H. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires. Allergy. 2008;63:284 -291.
18. Guidance for industry. patient-reported outcomes measures: use in medical product development to support labeling claims. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Available online at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM193282.pdf. Accessed December 2009.
19. Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46:266 -274.
20. Rogers WH, Adler DA, Bungay KM, Wilson IB. Depression screening instruments made good severity measures in a cross-sectional analysis. J Clin Epidemiol. 2005;58:370 -377.
21. Szeinbach SL, Seoane-Vazquez EC, Beyer A, Williams PB. The impact of allergic rhinitis on work productivity. Prim Care Respir J. 2007;16: 98-105.
22. Stull DE, Roberts L, Frank L, Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin. 2007; 23:811- 819.
23. van Hoecke H, Vastesaeger N, Dewulf L, Sys L, van Cauwenberge P. Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy. 2006;61:705-711.
24. Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med. 2006;166:1744 -1748.
25. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59-65.